Skip to main content

Table 2 Short-term surgical outcomes of NE and E patients who underwent gastrectomy for pT1-T2 gastric cancer

From: Surgical treatment outcomes of patients with T1-T2 gastric cancer: does the age matter when excellent treatment results are expected?

Factors Group NE (< 70 years) Group E (≥ 70 years) p value
Operation time: min (mean ± SD; min-max) 146.9 ± 41.58 143.72 ± 44.53 0.432
Blood loss: ml (mean ± SD; min-max) 171.82 ± 137.11 169.50 ± 136.50 0.879
ICU stay: days (mean ± SD; min-max) 1.24 ± 1.24 2.23 ± 6.30 0.014
Postoperative hospital stay: days (mean ± SD; min-max) 13.07 ± 5.86 14.05 ± 8.24 0.145
Dissected lymph nodes (mean ± SD) 22.18 ± 10.28 19.50 ± 9.43 0.005
Curability R0 259 (97.0%) 182 (95.8%) 0.484
R1,2 8 (3.0%) 8 (4.2%)
Postoperative complications: n (%) 55/267 (20.5%) 51/190 (26.8%) 0.144
Surgical complications 29/267 (10.8%) 20/190 (10.5%) 0.909
Anastomotic leakage 2/267 (0.7%) 5/190 (2.6%) 0.133
Postoperative bleeding 6/267 (2.2%) 4/190 (2.1%) 0.999
Peritonitis/ intraabdominal abscess 5/267 (1.8%) 3/190 (1.5%) 0.999
Ileus 3/267 (1.1%) 0/190 (0.0%) 0.269
Incisional surgical site infection and (or) eventration 5/267 (1.8%) 4/190 (2.1%) 0.999
Postoperative pancreatitis 5/267 (1.8%) 2/190 (1.0%) 0.704
Pancreatic/biliary/enterocutaneuos fistula 3/267 (1.1%) 2/190 (1.0%) 0.999
Medical complications 26/267 (9.7%) 31/190 (16.3%) 0.043
Cardiac insufficiency 0/267 (0.0%) 3/190 (1.5%) 0.071
Pneumonia 11/267 (4.1%) 4/190 (2.1%) 0.292
Sepsis 0/267 (0.0%) 3/190 (1.5%) 0.071
PATE 0/267 (0.0%) 2/190 (1.0%) 0.172
Other 15/267 (5.6%) 19/190 (10.0%) 0.102
Clavien-Dindo 1–2 39 (14.6%) 30 (15.8%) 0.195
3–4 16 (6.0%) 10 (5.3%)
Postoperative mortality: n (%) 0 (0.0%) 11 (5.7%) 0.001